One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
The fascinating story of lipid-lowering drugs, sodium-glucose co-transporter 2 inhibitors and GLP1-R agonists: new light shed on their beneficial effects
doi : 10.1093/eurheartj/ehae586
Volume 45, Issue 35, 14 September 2024
Multi-stakeholder workshop on reducing population-wide dietary sodium intake in Nigeria
Weekly Journal Scan: an ounce of PREVENTion is worth more than a pound of stents
Artificial intelligence-enhanced patient evaluation: bridging art and science
Lipid lowering for prevention of venous thromboembolism: a network meta-analysis
From arteries to veins: the expanding role of lipid-lowering drugs in preventing thrombosis
Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis
Familial hypercholesterolaemia: need for equitable treatment in women and men
Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials
STEPping down diuretic therapy with semaglutide in obesity-related heart failure with preserved ejection fraction: decongestion or disease modification?
Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study
Pulmonary hypertension in heart failure: the good, the bad, and the ugly
Single-nucleus RNA sequencing identifies cell-type–specific effects of sodium-glucose co-transporter 2 inhibitors in human myocardial slices
Pulsus alternans under left ventricular assist device in a patient with dilated cardiomyopathy and LMNA mutation
The role of natural compensatory mechanisms in complex congenital heart disease: haemodynamic evolution and clinical outcomes in a case of Cor triatriatum sinistrum syndrome
Correction to: Atherosclerosis in ancient mummified humans: the global HORUS study
